- Staat
- WA
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 25.10.2021
- Impfdatum
- 07.10.2021
- Beginn
- 08.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Unresponsive to stimuli
Symptomtext
Patient unresponsive the following morning
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CAD in native artery, essention HTN, Hyperlipidemia, Hypertensive heart disease without CHF, retinal artery branch occlusion on of L eye, glaucoma, NSTEMI, arthritis bilateral hands, chronic diastolic heart failure, physical deconditioning, stroke
- Andere Medikamente
- aspirin 81mg, azelastine nasal spray, carvedilol 6.25mg bid, vitamin D3, vitamin B12, folic acid 1mg , furosemide 40mg, hydralazine 10mg q6 hours PRN, melatonin 3mg, olmesartan5mg, omeprazole 20mg, Klor Con 20meq, Rosuvastatin 20mg
- Allergien
- levaquin, rocephin
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 13.06.2022
- Impfdatum
- 04.02.2022
- Beginn
- 06.06.2022
- Tage bis Beginn
- 122,0
- Dosis
- N/A
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angiogram pulmonary normal
Blood culture positive
COVID-19
Chest X-ray normal
Condition aggravated
Corynebacterium test positive
Culture urine negative
Glycosylated haemoglobin increased
Hypotension
Hypovolaemia
Hypovolaemic shock
Intensive care
SARS-CoV-2 test positive
Shock
Urinary tract infection
Urine analysis abnormal
Urine leukocyte esterase positive
Symptomtext
Primary Care Physician at Discharge: Doctor Hematologist/Oncologist: Doctor Admission Date: 6/6/2022 Discharge Date: 06/10/2022 Patient's Discharge Disposition: Home in stable condition. PRESENTING PROBLEM: Shock Hypotension, unspecified hypotension type COVID-19 UTI (urinary tract infection) Hospital Course: This is a 70 y.o. year old patient who was admitted on 6/6/2022 with PMH of IgG kappa multiple myeloma, HTN, hyperthyroidism, and type II DM. She was admitted with severe hypotension requiring ICU and pressors. Her hypovolemic shock was thought secondary to volume depletion which responded to fluid resuscitation, and patient was able to come off pressors on 6/7. She was treated with stress dose steroids in setting of shock but was weaned off steroids on 6/8 without any recurrence of low blood pressure. Blood cultures were positive for corynebacterium aurimucosum, however this was likely a contaminant. She was also incidentally found to be COVID positive, however she continued on room air and CXR/CTA chest did not show any acute pulmonary process. Her urinalysis showed moderate leukocytes, however her urine culture was negative. Given negative urine culture, she was taken off antibiotics on 6/9 without any recurrence of symptoms or worsening ROS. She was treated with Remdesivir on 6/8 and 6/9 but did not need to complete entire course given overall improvement and stability. Patient deemed stable for discharge on 6/10. Prior to discharge today, patient is feeling well. She is on room air without SOB. Patient eating/drinking/voiding well and ambulating as tolerated. Patient will plan to follow up in our office with the NP on 6/14. She is due for her next cycle of daratumumab on 6/20/22. She was encouraged to follow-up with her PCP for blood pressure and diabetes management given her elevated A1C and that blood pressure medications were stopped with hypotension. Patient's discharge medications and instructions were discussed as per below and new prescriptions were sent to patient's requested pharmacy prior to discharge. All questions answered. Patient is aware to call our office should further questions or concerns arise following this discharge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypovolaemic shock
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Lytic bone lesions on xray Type 2 diabetes mellitus with hyperglycemia Cancer related pain Multiple myeloma Cerebrovascular accident (CVA) due to stenosis of right posterior cerebral artery Hypothyroidism Hypertension associated with diabetes Septic shock COVID-19 virus infection Shock
- Andere Medikamente
- Accu-Chek FastClix Lancets Accu-Chek Softclix Lancets acetaminophen (TYLENOL) 500 MG tablet aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 20 MG tablet blood glucose test strips (ACCU-CHEK GUIDE) insulin glargine (LANTUS SOLOSTA
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- 01.11.2021
- Beginn
- 15.10.2022
- Tage bis Beginn
- 348,0
- Dosis
- N/A
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Asthenia
Bladder catheterisation
Bladder dilatation
Bladder wall calcification
Blood urine present
COVID-19
Computerised tomogram abdomen abnormal
Condition aggravated
Culture urine positive
Dehydration
Diarrhoea
Enterococcus test positive
Fatigue
Hypoxia
Laboratory test abnormal
Leukocytosis
Respiratory disorder
Symptomtext
Discharge Provider: PRIVATE MD Primary Care Provider at Discharge: PRIVATE DO Admission Date: 10/15/2022 Discharge Date: 10/25/2022 PRESENTING PROBLEM: Dehydration [E86.0] Severe sepsis (HCC) [A41.9, R65.20] Sepsis due to urinary tract infection (HCC) [A41.9, N39.0] Diarrhea, unspecified type [R19.7] HOSPITAL COURSE: "84-year-old past medical history significant for type 2 diabetes, hypertension, chronic obstructive pulmonary disease, coronary artery disease, hyperlipidemia, history of MI who came to the ER complains of generalized weakness, fatigue. At baseline patient is oriented x2. After arrival, patient was found to be tachycardic, lab work showed leukocytosis of 24, AKI. CT abdomen/pelvis showed distended urinary bladder with tiny calcifications left ureterovesical junction which could reflect a recently passed calculus. Urine looked infected showing large leukocytes small blood. Urine culture collected. He was placed on 2 g Rocephin and given 3 L fluid resuscitation per sepsis protocol and admitted to Medicine. After admission, patient did improve with IV antibiotics. AKI quickly resolved. Urology was consulted for urinary retention which is felt to be acute on chronic, despite treatment with Flomax and Proscar. Urology recommended placement of Foley, commenting that it should NOT be removed at discharge, as the patient would have difficulty with intermittent straight cathing. Plan is for the patient to follow up with Urology as an outpatient for definitive plan. Urine culture finalized as Enterococcus Faecalis. ID was consulted and IV antibiotics switched to IV ampicillin. ID recommended treatment with IV ampicillin through 10/21. Patient was originally seen by PT/OT who recommended discharge to home. Patient was re-evaluated by therapy on 10/19, and at that time it was felt he would be better suited for discharge to subacute rehab. Referrals were made by care management, and the patient was set for discharge on 10/21/22 but the patient became hypoxic and was tachypenic and the discharge was cancelled. The patient was found to be COVID positive and he qualified for Dexamethasone and Remdisivir. Once the patient respiratory status improved, he was discharged to the facility in a stable condition
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 10,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Dysphagia Urinary retention Essential hypertension Hyperlipidemia COPD (chronic obstructive pulmonary disease) (HCC) Bladder outlet obstruction Unspecified severe protein-calorie malnutrition (HCC) Benign prostatic hyperplasia with urinary retention Coronary artery disease, unspecified vessel or lesion type, unspecified whether angina present, unspecified whether native or transplanted heart Hx of myocardial infarction PVD (peripheral vascular disease) (HCC) TIA (transient ischemic attack
- Andere Medikamente
- acetaminophen (TYLENOL) 325 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amLODIPine (NORVASC) 5 MG tablet aspirin 325 MG tablet bisacodyl (DULCOLAX) 10 MG suppository budesonide/formoterol
- Allergien
- Atorvastatin Nebivolol Simvastatin
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 07.10.2021
- Impfdatum
- 04.10.2021
- Beginn
- 04.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Gait inability
Hypoaesthesia
Paraesthesia
Symptomtext
Patients spouse describes that patient had numbness and tingling in feet and legs and was unable to walk unassisted several hours after receiving dose. Symptoms are starting to resolve and patient is ambulatory, but still having some numbness and tingling
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- Unknow
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- Ipratropium 0.06% nasal spray, synthroid 88mcg, omeprazole 40mg, sertraline 100mg, lorazepam 1mg, propranolol er 80mg, estradiol 1mg
- Allergien
- statins, codeine
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 09.11.2022
- Impfdatum
- 29.10.2021
- Beginn
- 02.11.2022
- Tage bis Beginn
- 369,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
COVID-19
Cerebral atrophy
Chest X-ray normal
Computerised tomogram head abnormal
Cough
Electrocardiogram normal
Encephalopathy
Exposure to SARS-CoV-2
Face injury
Fall
Full blood count normal
Memory impairment
Metabolic function test normal
Pyrexia
SARS-CoV-2 test positive
Urine analysis normal
Symptomtext
Discharge Provider: MD Primary Care Provider : MD Admitting Service: Internal Medicine Service Admission Date: 11/2/2022 Discharge Date: 11/08/2022 PRESENTING PROBLEM: Acute encephalopathy HOSPITAL COURSE: Patient is an 82-year-old male with a past medical history significant for hypertension, PCA CVA, dementia, alcohol use disorder remotely who presented to the emergency department with a chief complaint of 2 falls in the 48 hours prior to admission. The patient tested positive for COVID-19 on 11/01/2022 with a home test. He had mild symptoms of fever and dry cough. His wife also was sick with COVID-19 and was unable to care for him due to generalized weakness and falls in the setting of dementia. His memory issues had worsened with his acute illness. He fell on the day prior to admission and hit his face per his wife's report. He was brought to the emergency department. In the emergency department, he was hemodynamically stable, not hypoxic and afebrile. Complete blood count and CMP were unremarkable. COVID-19 PCR was positive. Urinalysis was negative for infection. EKG showed normal sinus rhythm. Chest x-ray was unremarkable. CT head showed moderate volume loss and old right PCA CVA without acute process. He was given fluids and Tylenol. He was admitted to the hospitalist service for COVID-19 with fall and placement. PT/OT re-evaluated him on 11/07/2022. They recommended Home with home health, eventually discharged home in relatively stable condition on 11/08/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Oropharyngeal dysphagia Essential hypertension Mixed dementia (HCC) Ulcerative esophagitis Vitamin B 12 deficiency Macular degeneration Glaucoma Charcot-Marie-Tooth disease hyperlipidemia Moderate episode of recurrent major depressive disorder (HCC) Rhinophyma History of stroke History of alcoholism (HCC) Tubular adenoma Elevated bilirubin History of partial colectomy Advance care planning Weight gain Falls Generalized weakness
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet Ascorbic Acid (VITAMIN C GUMMIE PO) aspirin 81 MG enteric coated tablet Carboxymethylcellul-Glycerin (REFRESH OPTIVE) 0.5-0.9 % SOLN clopidogrel (PLAVIX) 75 MG tablet Cyanocobalamin (B-12 PO) escitalopr
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 01.12.2021
- Impfdatum
- 26.11.2021
- Beginn
- 29.11.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Symptomtext
Patient complained of the pain at the injection site but no swelling, redness, bleeding or hard to touch or fever.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- We suggested him to see the doctor to find out if there is an infection or adverse reaction but he said no, he just waits for a few more days.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknow
- Andere Medikamente
- N?A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 04.11.2021
- Impfdatum
- 08.10.2021
- Beginn
- 08.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bursitis
Injection site pain
Pain
Symptomtext
2 hour after injection pain subdeltoid. over the next 3 week progressive pain in deltoid bursae are with lifting her left arm. I saw the patient today 11/4/21 and started patient on physical therapy and warm compress and ibuprofen 400 mg + tylenol 500 mg every 8 hr as need for pain. Patient appears to have a subdeltoid bursititis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- no test. Physical exam only
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- obesity
- Andere Medikamente
- Not on any medication at the time of vaccination
- Allergien
- Bee stings
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 10.10.2021
- Impfdatum
- 07.10.2021
- Beginn
- 07.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site warmth
Malaise
Pyrexia
Symptomtext
Patient called back on 10/10/2021. She said the arm where she got the Covid shot in is red and hot to the touch. She also said she has low grade fever and feels sick. Patient was informed that the symptoms are in line with some of the possible vaccine side effects but also advised to contact their doctor and if symptoms got worse to seek medical help. Patient could not give exact time when the symptoms started but roughly referred to them as being later the same day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- As of now I do not have the information about outcome or medical help sought if any.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diabetes, Asthma, Hypertension
- Andere Medikamente
- -
- Allergien
- Latex
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 09.10.2021
- Impfdatum
- 05.10.2021
- Beginn
- 07.10.2021
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site rash
Pruritus
Urticaria
Symptomtext
PATIENT REPORTS RASH AND WELTS NEAR INJECTION SITE THAT OCCURRED 3 DAYS AFTER THE SHOT. SHE SAYS SHE FEELS EXTREMELY ITCHY ALL OVER HER BODY. SHE STATES THAT SHE HAS NEVER HAD A REACTION TO THE FLU SHOT BEFORE AND THINKS THIS IS DUE TO THE COVID SHOT.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site rash
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- BP, DM
- Andere Medikamente
- LOVASTATIN, IRBESARTAN, TRESIBA,LEVOTHYROXINE, CARVEDILOL, FUROSEMIDE
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 09.10.2021
- Impfdatum
- 06.10.2021
- Beginn
- 07.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Eye pruritus
Pain in extremity
Peripheral swelling
Skin reaction
Symptomtext
Patient received a high dose flu shot from the pharmacy on 10/6/21. She came by on 10/9/21 and stated that the next day after the shot on 10/7/21 her warm was swollen and red and itchy and sore. It has not gotten better since that day. She was advised to apply ice on it and also call the doctor. She said she will call the doctor today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Eye pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- not known
- Vorgeschichte
- not known
- Andere Medikamente
- not known
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 07.10.2021
- Impfdatum
- 06.10.2021
- Beginn
- 06.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Feeling of body temperature change
Headache
Symptomtext
PATIENT CALLED @9:30AM 10/7 AND STATED THAT SHE HAD CHILLS AND WAS HOT AND COLD BUT NO FEVER @6PM ON 10/6, THE DATE SHE RECIEVED HER SHOT. SHE TOOK TYLENOL AND THEN AGAIN 4 HOURS LATER. SHE HAD A HEADACHE THIS MORNING AND TOOK TYLENOL AGAIN. CHECKED BACK IN WITH PATIENT AROUND 6PM AND SHE STATED HER SYMPTONS RESOLVED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- HYPERTENSION, HEART DISEASE
- Andere Medikamente
- PRAVASTATIN, DILTIAZEM
- Allergien
- CODEINE
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 29.09.2021
- Impfdatum
- 28.09.2021
- Beginn
- 28.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Urticaria
Symptomtext
The patient called stating she had random hives and joint pains that began several hours after receiving both the Fluzone HD and the Pfiizer Covid vaccine. She was not having any swelling of the mouth or throat and no difficulty breathing. I advised her to contact her doctor but she does not have one currently. I then advised her to keep an eye on the reaction and go to the ER if she does experience difficulty breathing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Amoxicillin, Hydrocodone, Clindamycin
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 06.11.2021
- Impfdatum
- 06.11.2021
- Beginn
- 06.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
pt is not 65+ years old but was administered this dose in error
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 29.10.2021
- Impfdatum
- 28.10.2021
- Beginn
- 28.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Pt is 61 years old and received the High Dose by mistake.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Asthma
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 29.10.2021
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syringe issue
Underdose
Symptomtext
The syringe leaked per patient. And he believed that he didn't receive the full dose. I reached out to the manufacturer and got an expert clinical advise and they said that CDC recommend to redo the vaccine per this incident/scenario. I called the patient and told him they are offering him the shot for free. He said he will come and get the dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syringe issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 21.10.2021
- Impfdatum
- 21.10.2021
- Beginn
- 21.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
patient came in for a pneumonia vaccine our immunization selection tool recommended pneumovax 23 but patient got Prevnar 13
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 99,0
- Geschlecht
- F
- Eingang
- 21.10.2021
- Impfdatum
- 21.10.2021
- Beginn
- 21.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Immunodeficiency
Wrong product administered
Symptomtext
patient was due for Prevnar 13 but got pneumovax 23
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Immunodeficiency
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- patient needed Prevnar 13 but received pneumovax 23
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 13.10.2021
- Impfdatum
- 12.10.2021
- Beginn
- 12.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood test
Injury associated with device
Symptomtext
Pharmacist administered vaccine to patient , readjusted seating and needle then grazed the inside of thumb. Both source individual and pharmacist went for blood testing. Will hear back in 1-5 business days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood test
- Hospital-Tage
- -
- Labordaten
- oth source individual and pharmacist went for blood testing. Will hear back in 1-5 business days.
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- Yaz
- Allergien
- PCN allergy
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- -
- Geschlecht
- M
- Eingang
- 09.10.2021
- Impfdatum
- 01.10.2021
- Beginn
- 01.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Device connection issue
Syringe issue
Underdose
Symptomtext
Vaccine leaked out of the syringe where the needle and syringe meet with no reported adverse event; Initial information received on 01-Oct-2021 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age male patient for it was reported vaccine leaked out of the syringe where the needle and syringe meet (underdose) while receiving INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT]. The patient medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 01-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [Oral solution ,pre filled syringe,lot UJ763AC and expiry date: 30-Jun-2022] via an intramuscular route in unknown administration site for prophylactic vaccination. It was reported "FLUZONE HIGH DOSE QUADRIVALENT to a patient today and noted that some of the vaccine leaked out of the syringe where the needle and syringe meet. Leaking (gather as much info as possible)-syringe looked like it was connected-some got out of injection o where is it leaking from? (use vial & syringe guides). Clear location of the leakage (under the Luer-Lok adaptor, out of the vial stopper puncture mark)- leur lok where needed is inserted o When did the leakage occur (e.g. when removing unit from the box, when attaching needle, when injecting diluent into powder vial, when administering the dose)-leaking occurred during injection. leak (e.g. only a few droplets or half the dose)-1/2 Amount o Diluent or vaccine leaking." No other vaccines were reported. It was case of actual medication error due to underdose [Latency: on the same day]. Details of laboratory data not reported. It was not reported if the patient received any corrective treatment for the event. At time of reporting, the outcome was unknown for the event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Device connection issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 09.10.2021
- Impfdatum
- 29.09.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
shipment of FLUZONE HD QIV was delivered too late. It was supposed to have been returned but it wasn't / no reported AE; Initial information was received on 30-Sep-2021 regarding an unsolicited valid non-serious case from a pharmacist via regulatory authority (under reference 00792823). This case involves a 72-year-old female patient who was administered with INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] of which the shipment was delivered too late and it was supposed to have been returned but it was not, and three doses were administered (product storage error). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 29-Sep-2021, the patient received a dose of 0.7mL suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ763AC, expiry date 30-Jun-2022 ) via intramuscular route in the left arm for prophylactic vaccination. It was an actual case of medication error due to incorrect product storage. It was reported "pharmacist/manager states a shipment of FLUZONE HIGH DOSE (HD) Quadrivalent (QIV) (522 - FLZ HD HV QIV) was delivered too late and caller had already spoken to Pasteur CS. However, 3 of the vaccines in the shipment were administered to patients so Pasteur CS transferred her to us to get more information about how to move forward. Call transferred from Pasteur agent Caller states that they received a shipment of FLUZONE HIGH DOSE that has been in transit for a few days. It was supposed to have been returned but it was not, and three doses were administered." At time of reporting, no adverse event was reported and the outcome was unknown for the reported event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- -
- Geschlecht
- F
- Eingang
- 09.10.2021
- Impfdatum
- 29.09.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product distribution issue
Product storage error
Symptomtext
a shipment of FLUZONE HD QIV was delivered too late and caller had already spoken. However, 3 of the vaccines in the shipment were administered to patients, no AE; Initial information regarding an unsolicited valid non-serious case was received from a Pharmacist via Agency inbound (reference number- 00792822) and transmitted to Sanofi on 30-Sep-2021. This case involves INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] whose shipment was delivered too late, However, the vaccines in the shipment was administered to an 86 year old female patient (product storage error). The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On 29-Sep-2021, the patient received a dose (0.7ml) of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number: UJ763AC; expiry date: 30-Jun-2022) via intramuscular route in the left arm for prophylactic vaccination. It was case of actual medication error due to incorrect product storage (latency: unknown). It was reported "Pharmacist states a shipment of FLUZONE HD QIV was delivered too late and caller had already spoken. However, 3 of the vaccines in the shipment were administered to patients." Also, the reporter mentioned that the shipment had been in transit for a few days. It was supposed to have been returned but it was not. No adverse events were reported at the time of this report. At the time of this report, the outcome of the event was unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 09.10.2021
- Impfdatum
- 29.09.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
they received a shipment of FLUZONE HIGH DOSE that has been in transit for a few days. It was supposed to have been returned but it wasn't and three doses were administered, no AE; Initial information was received on 30-Sep-2021 regarding an unsolicited valid non-serious case from a pharmacist via regulatory authority (under reference 00792823). This case involves a 74 year old male patient who was administered with INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] of which the shipment was delivered too late and it was supposed to have been returned but it was not, and three doses were administered (product storage error). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 29-Sep-2021, the patient received a 0.7 ml dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ763AC and expiry date: 30-Jun-2022, Frequency: once) via an intramuscular route in the left upper arm for prophylactic vaccination. It was an actual case of medication error due to incorrect product storage. It was reported "pharmacist/manager states a shipment of FLUZONE HIGH DOSE (HD) Quadrivalent (QIV) (522 - FLZ HD HV QIV) was delivered too late and caller had already spoken to Pasteur CS. However, 3 of the vaccines in the shipment were administered to patients so Pasteur CS transferred her to us to get more information about how to move forward. Call transferred from Pasteur agent Caller states that they received a shipment of FLUZONE HIGH DOSE that has been in transit for a few days. It was supposed to have been returned but it was not, and three doses were administered." At time of reporting, no adverse event was reported and the outcome was unknown for the reported event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 05.10.2021
- Impfdatum
- 05.10.2021
- Beginn
- 05.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood test
Injury associated with device
Symptomtext
needlestick to associate after adminstering shot
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood test
- Hospital-Tage
- -
- Labordaten
- blood test
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -